Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been admitted to hospital with a blockage in a large blood vessel in the brain and are being treated with a device called the Tigertriever, according to its approved instructions for use.
- People for whom the Tigertriever was used as the first treatment attempted in the affected blood vessel.
- People who have provided signed informed consent to participate.
- People aged between 18 and 75 years (inclusive).
- People who had little to no disability before their stroke (a pre-stroke score of 0 or 1 on a standard disability scale).
Who may not be able to join:
- People who had any other device used to clear the blocked vessel before the Tigertriever was used, including suction-based catheters.
- People who showed signs of bleeding in the brain on a CT or MRI scan at the time of admission.
- People who have had a brain bleed, stroke, clot-dissolving treatment, or a procedure to open blocked blood vessels within the past 3 months.
- People with a suspected condition called cerebral amyloid angiopathy (a disease affecting blood vessels in the brain — confirm with trial site).
- People who were diagnosed with dementia before their stroke, or who were taking a type of medication called cholinesterase inhibitors prior to their stroke.
- People who were diagnosed with, or were being treated for, major depression before their stroke.
- People who had a learning or intellectual disability before their stroke.
- People who are not expected to be available for a follow-up assessment at 6 months after treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +972 72 2503331
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Association between successful reperfusion* and cognitive benefit**
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.